Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Thomas

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
American Heart Journal Plus : Cardiology Research and Practice|March 4, 2024
Post-intensive cardiac care outpatient long-term outreach clinic (PICCOLO clinic): Defining health care needs and outcomes among coronary care unit survivorsChristopher K Mason, Sara K Adie, Michael J Shea, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 1, 2024
A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumoniaOwen R Albin, Jonathan P Troost, Louis Saravolatz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2025
Corrigendum to "A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumonia" [Clin Microbiol Infect 30 (2024) 499-506]Owen R Albin, Jonathan P Troost, Louis Saravolatz, et al.
Journal of Thrombosis and Thrombolysis|February 11, 2012
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparinMichael P Thomas, Kenneth W Mahaffey, Karen Chiswell, et al.
Plos One|September 18, 2015
Percutaneous Coronary Intervention Utilization and Appropriateness across the United StatesMichael P Thomas, Craig S Parzynski, Jeptha P Curtis, et al.
Cell Biochemistry and Biophysics|June 12, 2013
Absolute quantification of E1, ubiquitin-like proteins and Nedd8-MLN4924 adduct by mass spectrometryXiaofeng Yang, James E Brownell, Qing Xu, et al.
Molecular Cancer Therapeutics|March 28, 2014
Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathwaysKhristofer Garcia, Jonathan L Blank, David C Bouck, et al.
Journal of the National Cancer Institute|May 17, 2007
Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formationImtiaz A Mawji, Craig D Simpson, Rose Hurren, et al.
Blood|June 8, 2010
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphomaMichael A Milhollen, Tary Traore, Jennifer Adams-Duffy, et al.
Cancer Cell|March 24, 2012
Treatment-emergent mutations in NAEβ confer resistance to the NEDD8-activating enzyme inhibitor MLN4924Michael A Milhollen, Michael P Thomas, Usha Narayanan, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
American Heart Journal Plus : Cardiology Research and Practice|March 4, 2024
Post-intensive cardiac care outpatient long-term outreach clinic (PICCOLO clinic): Defining health care needs and outcomes among coronary care unit survivorsChristopher K Mason, Sara K Adie, Michael J Shea, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 1, 2024
A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumoniaOwen R Albin, Jonathan P Troost, Louis Saravolatz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2025
Corrigendum to "A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumonia" [Clin Microbiol Infect 30 (2024) 499-506]Owen R Albin, Jonathan P Troost, Louis Saravolatz, et al.
Journal of Thrombosis and Thrombolysis|February 11, 2012
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparinMichael P Thomas, Kenneth W Mahaffey, Karen Chiswell, et al.
Plos One|September 18, 2015
Percutaneous Coronary Intervention Utilization and Appropriateness across the United StatesMichael P Thomas, Craig S Parzynski, Jeptha P Curtis, et al.
Cell Biochemistry and Biophysics|June 12, 2013
Absolute quantification of E1, ubiquitin-like proteins and Nedd8-MLN4924 adduct by mass spectrometryXiaofeng Yang, James E Brownell, Qing Xu, et al.
Molecular Cancer Therapeutics|March 28, 2014
Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathwaysKhristofer Garcia, Jonathan L Blank, David C Bouck, et al.
Journal of the National Cancer Institute|May 17, 2007
Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formationImtiaz A Mawji, Craig D Simpson, Rose Hurren, et al.
Blood|June 8, 2010
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphomaMichael A Milhollen, Tary Traore, Jennifer Adams-Duffy, et al.
Cancer Cell|March 24, 2012
Treatment-emergent mutations in NAEβ confer resistance to the NEDD8-activating enzyme inhibitor MLN4924Michael A Milhollen, Michael P Thomas, Usha Narayanan, et al.
Pageof 4